A new prognostic system for multiple myeloma based on easily available parameters
- 1 August 1989
- journal article
- research article
- Published by Wiley in British Journal of Haematology
- Vol. 72 (4), 507-511
- https://doi.org/10.1111/j.1365-2141.1989.tb04314.x
Abstract
Summary The prognostic significance of different presenting features in 180 patients with multiple myeloma (MM) from a single institution was analysed. Out of eight variables isolated from the univariate analysis only two (blood urea and serum albumin), were significant in the multivariate model. Derived from these two simple variables, the relative risk of each patient was calculated, and subsequently two subpopulations of patients could be recognized. The first group included patients with a very active myeloma and a high risk of death soon after diagnosis, their median survival being of only 11–6 months, and the second one comprised patients with low risk of death during the first year and a median survival of 28 months. A hazard function derived from two-thirds of the patient population (training group) was successfully validated in the remaining subset of patients (test group). Finally, the three major available myeloma staging systems (Durie & Salmon's, Merlini et al's, and the one proposed by the British Medical Research Council) were tested in the present series, and only the latter one showed prognostic validity.This publication has 27 references indexed in Scilit:
- Prognostic factors and staging systems for multiple myeloma: Comparisons between the medical research council studies in the United Kingdom and the Southwest oncology group studies in the United StatesHematological Oncology, 1988
- Race, poverty, and survival in multiple myelomaCancer, 1984
- Critical Study of Staging in Multiple MyelomaScandinavian Journal of Haematology, 1983
- Prognostic Value of the Staging System Proposed by Merlini, Waldenström and Jayakar for Multiple MyelomaActa Haematologica, 1983
- The Chemotherapy of Plasma-Cell Myeloma and the Incidence of Acute LeukemiaNew England Journal of Medicine, 1979
- Prognostic Factors in Multiple MyelomaActa Haematologica, 1978
- Prognostic factors in multiple myelomaCancer, 1975
- 352. Note: Conservatism of the Approximation Σ(O - E) 2 /E in the Logrank Test for Survival Data or Tumor Incidence DataBiometrics, 1973
- Urea, albumin, and response rates.BMJ, 1971
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958